Human primary ductal carcinoma in situ (DCIS) subtype-specific pathology is preserved in a mouse intraductal (MIND) xenograft model
about
Next-generation sequencing: a powerful tool for the discovery of molecular markers in breast ductal carcinoma in situPatient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition.Microfluidic model of ductal carcinoma in situ with 3D, organotypic structure.Humanization of the mouse mammary gland by replacement of the luminal layer with genetically engineered preneoplastic human cellsHuman cancer growth and therapy in immunodeficient mouse models.Subcapsular transplantation of tissue in the kidney.Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasionA novel role of microRNA146b in promoting mammary alveolar progenitor cell maintenance.Mouse Mammary Intraductal (MIND) Method for Transplantation of Patient Derived Primary DCIS Cells and Cell Lines.Metalloproteinase-disintegrin ADAM12 is associated with a breast tumor-initiating cell phenotype.Effective treatment of ductal carcinoma in situ with a HER-2- targeted alpha-particle emitting radionuclide in a preclinical model of human breast cancer.Three-dimensional modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 modelXenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumors.Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ.Intra-mammary ductal transplantation: a tool to study premalignant progression.IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21.Focal adhesion kinase and Wnt signaling regulate human ductal carcinoma in situ stem cell activity and response to radiotherapy.Developing in vitro models of human ductal carcinoma in situ from primary tissue explants.Xenograft model for therapeutic drug testing in recurrent respiratory papillomatosis.New methods in mammary gland development and cancer: proteomics, epigenetics, symmetric division and metastasis.Comparison of the Adipose and Luminal Mammary Gland Compartment as Orthotopic Inoculation Sites in a 4T1-Based Immunocompetent Preclinical Model for Triple-Negative Breast Cancer.Chemokine Signaling Facilitates Early-Stage Breast Cancer Survival and Invasion through Fibroblast-Dependent Mechanisms.MIND model for triple-negative breast cancer in syngeneic mice for quick and sequential progression analysis of lung metastasis.Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer
P2860
Q26864448-B7F95225-2FBE-41AA-91E8-B94EC724D6ABQ33739184-084216BC-7976-48CA-9CD4-F4FBB4E87C84Q35008863-8307139F-4FAC-4EC7-A5A3-4980CA71E832Q35530169-E42CCC04-B452-445F-9641-336991D748C3Q35545282-8D86138C-9249-475C-B99E-3DE93C1E1ABDQ35545309-3C9AC596-4AC4-45DE-B510-C70CF0EADECDQ36071154-50D3F1B6-907B-46AF-90E4-67F2FAC98182Q36920898-9C3A1A0A-EB97-4F22-92A0-3592773526D2Q37109002-F1C4BA99-50AF-4D29-8DEA-F9E05E5DBA7CQ37352137-E3396FF3-16E9-415D-9ED3-81333B619380Q37362912-79CAF24C-0C01-49B3-B210-391DC3019ED9Q37371138-00D9D7B3-41F4-445A-8C46-60EA67C33E22Q37416460-93522AEF-B76B-4DF0-853D-98AFEBA19553Q37690034-4363A000-A776-43EE-A05B-3D68ECC326F7Q38017892-92D0D7CA-9FD0-496F-A2A3-2A7F3C344185Q38707618-F8EE5BBD-BBFC-4775-A9FB-F1FB7F6CC07DQ38960021-F78EC128-23A4-4A15-967D-772F2F275E39Q38973293-C987C24E-9923-4358-BA39-ED1583DD70A7Q42199851-EF503D54-03D1-40E5-9A5A-688823D9F055Q43128319-8AF20C78-F86F-4B0C-92D1-8FBEC30A8276Q45858997-FDD9C9BE-E902-4939-8184-6CC78F558B9EQ47604342-3ACF7991-5127-4076-B7B6-0AADB984094FQ54965481-B9881BD1-59A2-4369-A497-336AF07D3A52Q58777985-D4DA3489-D477-4CFD-B369-21FDF31FA685
P2860
Human primary ductal carcinoma in situ (DCIS) subtype-specific pathology is preserved in a mouse intraductal (MIND) xenograft model
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Human primary ductal carcinoma ...... aductal (MIND) xenograft model
@ast
Human primary ductal carcinoma ...... aductal (MIND) xenograft model
@en
type
label
Human primary ductal carcinoma ...... aductal (MIND) xenograft model
@ast
Human primary ductal carcinoma ...... aductal (MIND) xenograft model
@en
prefLabel
Human primary ductal carcinoma ...... aductal (MIND) xenograft model
@ast
Human primary ductal carcinoma ...... aductal (MIND) xenograft model
@en
P2093
P2860
P356
P1476
Human primary ductal carcinoma ...... aductal (MIND) xenograft model
@en
P2093
D Craig Allred
Daniel Medina
Fariba Behbod
Kelli Elizabeth Valdez
William Smith
P2860
P304
P356
10.1002/PATH.2969
P577
2011-09-26T00:00:00Z